Joern Meissner的动态

Join our webinar tomorrow: Advantages of Optimizing and Upgrading Your Nuclear Cardiology SPECT Lab ?? Tomorrow, November 5, 2024 ? 1 - 2 PM ET ?? REGISTER: https://hubs.ly/Q02WVxpf0 Learn practical strategies, understand financial considerations and gain firsthand knowledge from those who have navigated the complexities of SPECT upgrades. Don't miss out on this invaluable session designed to equip you with the tools for successful decision-making! Cardinal Health #NuclearCardiology #SPECTLab #HealthcareInnovation #ImagingSolutions

?? ???????????????????? & ?????????????????????????? ???? ?????????????? ???????????????? In our series finale, Prof Dr Rudi Dierckx highlights the key industry challenges and opportunities in nuclear medicine. ?? ???????? ???????????????????? ?????? ?????????????????????????? ???????????? ?????? ???????????????? ????????????????????? Let's start the discussion in the comments. ?? ?????????? ?????? ?????????? ????????????:? https://bit.ly/4aEGged ??????’?? ?????????? ?????? ???????????? ???? ???????????????????? ???????????????? ?? #NuclearMedicine #HealthcareInnovation #MedicalImaging #Radiopharmaceuticals

For conditions that go beyond what a CT scan or MRI can show, nuclear medicine provides a deeper look into blood flow, metabolism, and more. Learn how radiopharmaceuticals help us capture the unseen in this “Weekend Doctor Column,” ?? https://bvhs.info/4hJeYGM, written by Joy Johnson, CNMT, nuclear medicine lead technologist with Blanchard Valley Health System.

?? MEDIRAD survey update! In February 2022, the European-funded MEDIRAD project concluded, aiming to enhance the scientific basis and clinical practice of radiation protection in medicine. The project focused on understanding the health effects of low-dose ionising radiation from diagnostic and therapeutic procedures. As part of MEDIRAD, a large survey was conducted in 2019 to gather information on the use of multimodality imaging in nuclear medicine. Now, a follow-up survey has been developed to detect changes in the use of CT in nuclear medicine between 2019 and 2024. Participate now - it should not take more than 5 to 10 minutes! ?? https://lnkd.in/dpvEqtVs

In the radiopharmaceutical area, producing radioactive tracers for nuclear medicine imaging #nuclearmedicine #radiotracer #radiopharmacy #medicalphysics

Discover the potential of radiation monitoring in nuclear medicine and radiation therapy with Tracerco. Access our fact sheet to delve into the capabilities of our advanced radiation monitors in ensuring the safety of your clinical practice and the well-being of your patients and public. ?https://hubs.ly/Q02ytjXs0 #radiationsafety #radiationdetection

Happy Nuclear Medicine Week from SNMMI! Our Technologist Section President, Julie Bolin, MS, CNMT, FSNMMI-TS, talks about just how far nuclear medicine has come from the early days of treating thyroid cancer. (All the way back in the 1940s!) Today with the prominence of theranostics, nuclear medicine has the amazing potential to both detect and treat diseases like never before. Of course, all of this is thanks to the nuclear medicine professionals who work hard to specialize in this field, provide the highest quality of patient care, and who never stop researching and innovating to push our field forward. Here's to all of you! Don't forget to share your Nuclear Medicine Week pictures with us throughout the week. Take a pic in your merch or in your workplace and tag us @snm_mi and use #NUCMEDWEEK2024. More info on how nuclear medicine is revolutionizing healthcare: https://lnkd.in/e3x2KQxt

Nuclear medicine plays a vital role in patient care by supporting the diagnosis, management, and treatment of serious diseases. Through non-invasive imaging, nuclear medicine provides functional insights at the molecular and cellular level by tracking the uptake and metabolism of radiotracers in tissues. What makes this field so powerful is its ability to detect abnormalities early in the disease process, often before they are visible with other diagnostic tools. This early detection offers patients a better chance at timely treatment and improved outcomes. Nuclear medicine is at the forefront of precision medicine, providing essential tools for designing individualized treatments tailored to a patient’s genetic profile. A rapidly evolving area in this field is Theranostics, which combines diagnosis and therapy, allowing clinicians to 'see what you treat and treat what you see.' This approach uses diagnostic tools to identify disease and then treats it with the same or similar methods, maximizing therapeutic effectiveness while minimizing toxicity. Currently, Theranostics is making significant strides in treating thyroid, prostate, and neuroendocrine cancers.

Register for this upcoming webinar and learn the new CMS policy of "unbundling" for diagnostic radiopharmaceuticals. Speakers will discuss how this milestone policy achievement will impact industry, patient access, and the future of nuclear medicine. https://lnkd.in/ey_bZFHh

Discover the potential of radiation monitoring in nuclear medicine and radiation therapy with Tracerco. Access our fact sheet to delve into the capabilities of our advanced radiation monitors in ensuring the safety of your clinical practice and the well-being of your patients and public.